Erdal Çavuşoğlu
Erdal Çavuşoğlu publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Epidemiology, on topics such as Acute Myocardial Infarction Research, Adipokines, Inflammation, and Metabolic Diseases and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #2,945,697 of 7,710,434 ranked researchers
- Rank in United States
- #848,262 of 1,627,098
- Works
- 85
- Citations
- 2.4k
- Citations per work
- 28.2
What does Erdal Çavuşoğlu research?
Erdal Çavuşoğlu's work is mostly in Medicine (60%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5160.1%
- Medicine5160.1%
- Everything else3035.3%
- Life Sciences44.6%
- 1Cardiology and Cardiovascular Medicine33% of their works
- 2Surgery12% of their works
- 3Epidemiology6% of their works
- 4Immunology5% of their works
- 5Oncology5% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Acute Myocardial Infarction Research
- Adipokines, Inflammation, and Metabolic Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Inflammatory Biomarkers in Disease Prognosis
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Erdal Çavuşoğlu's research?
The keywords of their largest research topics: Cardiovascular Disease, Myocardial Infarction, Acute Coronary Syndromes, ST-Segment Elevation, Inflammation, Percutaneous Coronary Intervention, Diagnosis and Thrombosis.
- Vaccination
- Myocardial Revascularization
- Coronary Stents
- Cardiac Imaging
- Venous Thromboembolism
- Clopidogrel
- Obesity
- Thrombosis
- Percutaneous Coronary Intervention
- ST-Segment Elevation
- Myocardial Infarction
- Cardiovascular Disease
- Acute Coronary Syndromes
- Inflammation
- Diagnosis
- Adipose Tissue
- Aspirin
- Antithrombotic Therapy
- Cancer
- Coronary Artery Disease
- Immunity
- Heparin-Induced Thrombocytopenia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Cardiovascular Disease352 topics
- Myocardial Infarction312 topics
- Acute Coronary Syndromes231 topic
- ST-Segment Elevation231 topic
- Inflammation202 topics
- Percutaneous Coronary Intervention192 topics
- Diagnosis162 topics
- Thrombosis152 topics
- Adipose Tissue121 topic
- Obesity121 topic
- Aspirin111 topic
- Clopidogrel111 topic
- Antithrombotic Therapy91 topic
- Venous Thromboembolism91 topic
- Cancer81 topic
- Cardiac Imaging81 topic
- Coronary Artery Disease81 topic
- Coronary Stents81 topic
- Immunity81 topic
- Myocardial Revascularization81 topic
- Heparin-Induced Thrombocytopenia71 topic
- Vaccination71 topic
Where does Erdal Çavuşoğlu work?
Erdal Çavuşoğlu's main affiliation in the publication record is SUNY Downstate Health Sciences University, United States.
How many publications and citations does Erdal Çavuşoğlu have?
OpenAlex counts 85 works and 2,393 citations for Erdal Çavuşoğlu, an h-index of 26, ranking #2,945,697 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Erdal Çavuşoğlu. Posts are plain text and can be reported.